Page last updated: 2024-09-04

butylscopolammonium bromide and Neoplasms

butylscopolammonium bromide has been researched along with Neoplasms in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (11.11)	18.2507
2000's	6 (66.67)	29.6817
2010's	2 (22.22)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J	1
Aielli, F; Marinangeli, F; Masedu, F; Massici, A; Mercadante, S; Russo, D; Ursini, L; Valenti, M	1
Fujii, H; Iihara, H; Kobayashi, R; Matsuhashi, N; Suzuki, A; Takahashi, T; Yoshida, K; Yoshimi, C	1
Barcia, E; Luz Azuara, M; Negro, S; Reyes, R; Sánchez, Y	1
Edmonds, P; Lucas, C	1
Azuara, ML; Barcia, E; Martín, A; Negro, S; Sánchez, Y	1
Casuccio, A; Mangione, S; Mercadante, S	1
Azuara, ML; Barcia, E; Negro, S; Reyes, R; Sánchez, Y	1
Becker, R; Hamm, B; Hese, S; Kombächer, P; Weitzel, HK; Wolf, KJ	1

Reviews

1 review(s) available for butylscopolammonium bromide and Neoplasms

Article	Year
Medical treatment for inoperable malignant bowel obstruction: a qualitative systematic review. Journal of pain and symptom management, 2007, Volume: 33, Issue:2 Topics: Adrenal Cortex Hormones; Butylscopolammonium Bromide; Gastrointestinal Agents; Humans; Intestinal Obstruction; Muscarinic Antagonists; Neoplasms; Octreotide	2007

Trials

1 trial(s) available for butylscopolammonium bromide and Neoplasms

Article	Year
Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later. Journal of pain and symptom management, 2018, Volume: 56, Issue:6 Topics: Aged; Butylscopolammonium Bromide; Death; Disease Management; Drug Administration Schedule; Female; Humans; Kaplan-Meier Estimate; Male; Neoplasms; Palliative Care; Parasympatholytics; Respiratory Sounds; Terminal Care; Treatment Outcome	2018

Other Studies

7 other study(ies) available for butylscopolammonium bromide and Neoplasms

Article	Year
Chemical genetics reveals a complex functional ground state of neural stem cells. Nature chemical biology, 2007, Volume: 3, Issue:5 Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells	2007
Prophylactic effect of scopolamine butylbromide, a competitive antagonist of muscarinic acetylcholine receptor, on irinotecan-related cholinergic syndrome. Cancer chemotherapy and pharmacology, 2019, Volume: 83, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Butylscopolammonium Bromide; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Irinotecan; Japan; Male; Middle Aged; Muscarinic Antagonists; Neoplasms; Parasympathetic Nervous System; Risk Factors; Syndrome	2019
Compatibility of haloperidol and hyoscine-N-butyl bromide in mixtures for subcutaneous infusion to cancer patients in palliative care. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2003, Volume: 11, Issue:2 Topics: Antiemetics; Butylscopolammonium Bromide; Drug Interactions; Drug Stability; Drug Storage; Haloperidol; Humans; Injections, Subcutaneous; Muscarinic Antagonists; Neoplasms; Palliative Care; Time Factors	2003
A trial that failed because of poor recruitment. Palliative medicine, 2003, Volume: 17, Issue:6 Topics: Butylscopolammonium Bromide; Clinical Trials, Phase II as Topic; Humans; Intestinal Obstruction; Multicenter Studies as Topic; Neoplasms; Patient Selection	2003
Tramadol and hyoscine N-butyl bromide combined in infusion solutions: compatibility and stability. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2007, Volume: 15, Issue:1 Topics: Analgesics, Opioid; Butylscopolammonium Bromide; Drug Combinations; Drug Stability; Drug Storage; Humans; Infusion Pumps; Injections, Subcutaneous; Muscarinic Antagonists; Neoplasms; Pain; Palliative Care; Tramadol	2007
Physical compatibility and in vivo evaluation of drug mixtures for subcutaneous infusion to cancer patients in palliative care. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2002, Volume: 10, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Analgesics; Butylscopolammonium Bromide; Dexamethasone; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Haloperidol; Humans; Infusion Pumps; Male; Metoclopramide; Midazolam; Middle Aged; Morphine; Neoplasms; Palliative Care; Spain; Tramadol; Treatment Outcome	2002
[Tumors of the adnexa--a comparison of magnetic resonance tomography, endosonography and the histological findings]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1992, Volume: 156, Issue:4 Topics: Adnexa Uteri; Adnexal Diseases; Adolescent; Adult; Aged; Aged, 80 and over; Butylscopolammonium Bromide; Diagnosis, Differential; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasms; Prospective Studies; Ultrasonography	1992